To evaluate the efficacy of olezarsen (formerly AKCEA-APOCIII-LRx) on fasting triglyceride (TG) in patients with familial chylomicronaemia syndrome (FCS).
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
